10:06 <00226><00156><00655> - Joint Announcement & Resumption (1) The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from, or in reliance upon, the whole or any part of the contents of this announcement. LIPPO LIMITED * (Incorporated in Hong Kong with limited liability) (Stock Code: 226) LIPPO CHINA RESOURCES LIMITED * (Incorporated in Hong Kong with limited liability) (Stock Code: 156) HONGKONG CHINESE LIMITED * (Incorporated in Bermuda with limited liability) (Stock Code: 655) JOINT ANNOUNCEMENT MAJOR TRANSACTION FOR LIPPO LIMITED AND DISCLOSEABLE TRANSACTION FOR LIPPO CHINA RESOURCES LIMITED AND HONGKONG CHINESE LIMITED The board of directors of each of Lippo, HCL and LCR announces that on 21st January, 2005, the Purchaser, a wholly-owned subsidiary of HCL, entered into the Agreement with the Seller, for acquiring the land located at 83 Estrada de Cacilhas, Macau together with the buildings constructed thereon at a consideration of HK$238,000,000. Since the applicable percentage ratios for the purchase consideration payable by the Purchaser for acquiring the Property represent 5% or more but less than 25% for each of HCL and LCR, and represent 25% or more but less than 100% for Lippo, the entering into of the Agreement constitutes a discloseable transaction for each of HCL and LCR, and a major transaction for Lippo, under Chapter 14 of the Listing Rules. Accordingly, each of LCR, HCL and Lippo will, within 21 days after publication of this announcement, send a circular to their respective shareholders in accordance with rules 14.38 and 14.40 of the Listing Rules. Since the written approval from Lippo Cayman, being the controlling shareholder of Lippo, which as at the date of this announcement is interested in approximately 57.34% of the issued share capital of Lippo, has been obtained for the entering into of the Agreement in accordance with rule 14.44 of the Listing Rules, no extraordinary general meeting will be held by Lippo for approving the entering into of the Agreement. Trading in the shares of each of Lippo, HCL and LCR were suspended from 9:30 a.m. on 24th January, 2005 at the request of Lippo, HCL and LCR pending the publication of this announcement and applications have been made to the Stock Exchange for the resumption of trading of the shares of each of Lippo, HCL and LCR from 9:30 a.m. on 28th January, 2005.